Mariner
NUVB icon

Mariner’s Nuvation Bio NUVB Stock Holding History

Mariner’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$444K Buy
78,193
+22,792
+41% +$111K ﹤0.01% 2536
2026
Q1 		$238K Buy
55,401
+1,288
+2% +$7.17K ﹤0.01% 3055
2025
Q4 		$485K Sell
54,113
-4,297
-7% -$26.6K ﹤0.01% 2463
2025
Q3 		$216K Buy
58,410
+45,466
+351% +$124K ﹤0.01% 3109
2025
Q2 		$25.2K Buy
+12,944
New +$27K ﹤0.01% 3401
2023
Q4 		– Sell
-26,795
Closed -$35.9K – 3140
2023
Q3 		$35.9K Buy
+26,795
New +$44.6K ﹤0.01% 2805

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Mariner's NUVB Position: Q2 2026 in Review

Mariner increased its Nuvation Bio (NUVB) stake by 41% in Q2 2026, buying an estimated $111K and bringing the position to 78,193 shares worth $444K. The position accounts for ﹤0.01% of the portfolio, ranked #2536.

Mariner first reported a position in NUVB in Q3 2023 and has held it in 6 quarters since. The position peaked at $485K in Q4 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Mariner held 78,193 shares of Nuvation Bio worth $444K as of Q2 2026.
  • Mariner bought 22,792 Nuvation Bio shares in Q2 2026, an estimated $111K.
  • Nuvation Bio made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #2536 holding.
  • Mariner first reported a position in Nuvation Bio in Q3 2023 and has held it in 6 quarters since.
  • Mariner's Nuvation Bio position peaked at $485K in Q4 2025.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.